(Q28372550)

1

0 references

S Kinoshita

2

0 references

H Satoh

3

0 references

T Maeda

4

0 references

K Murakami

5

0 references

M Tsunoda

6

0 references

H Miyachi

7

0 references

K Awano

Bioorganic & Medicinal Chemistry Letters

8

0 references

language of work or name

English

0 references

publication date

22 February 1999

0 references

published in

0 references

volume

9

0 references

issue

4

0 references

page(s)

533-8

0 references

cites work

Diabetes complications: why is glucose potentially toxic?

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900039-6

7 January 2021

Effect of two years of strict metabolic control on progression of incipient nephropathy in insulin-dependent diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900039-6

7 January 2021

Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: the Oslo study

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900039-6

7 January 2021

Monitoring and controlling the patient with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900039-6

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900039-6

7 January 2021

Studies on antidiabetic agents. I. Synthesis of 5-[4-(2-methyl-2-phenylpropoxy)-benzyl]thiazolidine-2,4-dione (AL-321) and related compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900039-6

7 January 2021

Studies on hindered phenols and analogues. 1. Hypolipidemic and hypoglycemic agents with ability to inhibit lipid peroxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900039-6

7 January 2021

Studies on antidiabetic agents. X. Synthesis and biological activities of pioglitazone and related compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900039-6

7 January 2021

The synthesis of BRL 49653 - a novel and potent antihyperglycaemic agent

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900039-6

7 January 2021

Sulfated glycans stimulate endocytosis of the cellular isoform of the prion protein, PrPC, in cultured cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900039-6

7 January 2021

A novel insulin sensitizer acts as a coligand for peroxisome proliferator-activated receptor-alpha (PPAR-alpha) and PPAR-gamma: effect of PPAR-alpha activation on abnormal lipid metabolism in liver of Zucker fatty rats

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900039-6

7 January 2021